Abstract: BACKGROUND: We aim to assess the incidence, current treatment, and outcome of diverticulitis in highly immunosuppressed lung transplant recipients. METHODS: Retrospective analysis of a prospective database of 403 lung transplant recipients transplanted between 1992 and 2013 with a mean follow-up of 100 months (SD 58.0). RESULTS: 4.46% of lung transplant recipients (n=18) developed diverticulitis. Eight lung transplant recipients developed uncomplicated diverticulitis, which were all treated successfully with antibiotics. Three patients (37.5%) underwent elective sigmoid resection with severe Grade 3b complications after two of five (40%) surgical procedures. Diverticulitis recurrence occurred in five patients (60%). In total, 10 lung transplant recipients presented with 11 episodes of perforated diverticulitis with a 30-day mortality rate of 9.1%. Hartmann procedure was performed in eight lung transplant recipients. Sigmoid resection with primary anastomosis and protective ileostomy was performed in three patients with Hinchey I. Two of these patients developed anastomotic leakage with a secondary Hartmann procedure. CONCLUSION: Due to high leakage rate after resection with primary anastomosis and protective ileostomy in our cohort of lung transplant recipients with perforated diverticulitis, the Hartmann procedure seems to be the safer option. In contrast, in uncomplicated diverticulitis, non-operative treatment can be considered as a safe and highly successful treatment option, even for recurrences. 
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LTRs -lung transplant recipients HP-Hartmann's procedure Introduction Diverticular disease is a very common condition in Western societies with increasing prevalence. Complications of diverticular disease are acute uncomplicated diverticulitis and complicated diverticulitis including perforation as well as diverticular bleeding (1) . To date, limited data is available on the natural history of diverticulitis in immunosuppressed patients. The incidence of acute diverticulitis appears higher in immunosuppressed patients and development of complicated disease seems more likely (2, 3) .
It remains unclear, whether the recurrence rate after an uncomplicated episode is also higher in this population. A recent study found no difference in recurrence rate and the authors did not detect a significant difference in emergency surgery for recurrent disease in immunosuppressed vs. nonimmunosuppressed patients (4) . However, current guidelines recommend a low threshold for early elective surgery in immunosuppressed patients (5) .
Mortality and morbidity in emergency surgery have been shown to be significantly higher in immunosuppressed organ transplant recipients compared to their matched controls (3) . These differences in mortality or morbidity were not observed following elective surgery in immunosuppressed patients with diverticulitis (3). This was supported by data from a large nationwide retrospective review of colorectal surgeries in kidney transplant recipients, showing a low mortality and morbidity in kidney transplant patients undergoing colorectal surgery (6) . This might be due to a better preoperative health compared to other solid organ recipients as well as the need for intensified immunosuppression after heart or lung transplantation compared to kidney transplantation (3).
Receiving intensified (triple-) immunosuppression and given their close followup and the availability of data, we aimed to study the natural history of diverticulitis in lung transplant recipients. Specifically we aimed to critically analyze the paradigm to keep a low threshold for elective surgery in uncomplicated diverticulitis in immunosuppressed patients.
Materials and Methods
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Data
We retrospectively analyzed the prospective database of 403 lung transplant recipients at our institution between January 1992 and December 2013 and assessed patients with perforated and uncomplicated diverticulitis.
We analyzed age, gender, symptoms at time of diagnosis, time from lung transplant to colonic complication, time from onset of symptoms to treatment, laboratory values, radiologic findings, degree of colon complication, treatment of colonic complication, immunosuppression at presentation, change of immunosuppressive treatment, antibiotic treatment pre-and post-diagnosis, non-operative or surgical treatment strategy, morbidity, hospital stay, length of follow up and 30-day mortality. We also evaluated whether colonoscopies were performed prior to transplantation to assess preexisting diverticular disease.
Definitions
All lung transplant recipients with spontaneous lower abdominal pain and/ or tender abdomen upon palpation received either a CT scan or an MRI 8 for further workup. The diagnosis was made when inflamed diverticula with inflamed surrounding fatty tissue were detected on a CT-scan or MRI(7). In one patient diagnosis of a recurrent episode of non-perforated diverticulitis was based on clinical presentation, x-ray and sonography. We considered diverticulitis with any extraluminal air in the imaging as perforated diverticulitis.
In contrast we defined diverticulitis without signs of perforation as uncomplicated diverticulitis episodes.
Statistical analysis
All mean values and standard deviations (8) Mann-Whitney-U tests were performed to compare the experimental groups.
Differences were considered statistically significant if p<0.05. Analyses were conducted using Graph Pad prism Version 4.0b.
Results
Patient demographics and incidence of diverticulitis
Between (Table 3 ). Perforations occurred within 1 year of transplantation in 36.4% (4/11) of cases. The mean age at the time of diverticular perforation was 59.4 years (SD 7.0) ( Table 3 ). Mean FU after colonic perforation was 27.9 months (SD 42.2) ( Table 3) . At presentation one of these patients was hypotensive and required catecholamines. The remaining cases were normotensive. Two of eleven patients were tachycardic and two patients had fever (>38.5°C). Time from symptoms to treatment varied between 0.5 days and 3 days (mean 1.65 days, SD 1.0). The reason for transplantation were Langerhans-Histocytosis (n=1), pulmonary emphysema due to AT1-deficiency (n=6), endstage COPD (n=1), severe pulmonary hypertension (n=1) and cystic fibrosis (n=1).
In addition, eight lung transplant recipients had 12 episodes of uncomplicated diverticulitis at a mean FU of 122.8 months (SD 30.0) post transplant. The average age of these patients at time of the diverticular episode was 63 years (Table 3 ). Mean FU after uncomplicated diverticulitis episode was 61.7 months (SD 23.9) ( Table 3) . Patients with uncomplicated diverticulitis were normotensive (n=5) or hypertensive (n=7). Two patients with uncomplicated disease presented with fever. Time between symptoms and treatment varied between 0.5 and 6 days (mean 2.31 days, SD 1.95).
The underlying diagnoses leading to lung transplantation in patients with uncomplicated diverticulitis were chronic obstructive lung disease (n=4), alpha-1-AT-deficiency with lung emphysema (n=2), idiopathic lung fibrosis (n=1), and Kartagener-Syndrome (n=1).
With exception of one patient who received tacrolimus instead of cyclosporine due to insufficiently controllable drug levels within the first month after transplantation, all patients received cyclosporine, mycophenolate and prednisone ( Table 4 ). The immunosuppression regime did not change over time. Immunosuppression was not routinely changed upon the diagnosis of diverticulitis. However, in case of expected surgical intervention we routinely reduced mycophenolate by 1/3 to 1/2 of the dose. If differential blood count showed a trend towards cytopenia we further reduced the mycophenolate dose to avoid neutropenia (9).
Treatment and Outcome of Complicated Diverticulitis
Of the 10 patients presenting with 11 episodes of perforated diverticulitis all were treated surgically. HP was performed in 8 patients with Thus in our experience of 3 cases, performing a primary anastomosis in highly immunosuppressed patients with a perforated sigmoid diverticulitis, even in Hinchey I situations, the risk for anastomotic leakage is extremely high.
Colostomy reversal
Only 20% (2/10) of patients with colostomy have had a reversal of the colostomy at 16 and 7 months after the primary surgery within a mean FU of Thus, only a minority of patients have a colostomy reversal with a reasonable postoperative morbidity.
Treatment and Outcome of Uncomplicated Diverticulitis
Of the 8 LTRs with uncomplicated diverticulitis all were treated successfully with broad spectrum i.v. antibiotics and oral food intake restriction. Three of these patients received elective resection at a mean of Table 2) .
Of note, one patient with elective laparoscopic resection, protective ileostomy and ileostomy reversal with an entirely uneventful course presented with a rectum perforation most probably due to a perforated diverticulum 6 years after sigmoid resection.
Discussion
In this monocentric study we analyze the incidence and outcome of sigmoid diverticulitis in a large number of lung transplant recipients with a long follow-up and no loss to follow-up. Our study includes complicated-and uncomplicated diverticulitis and thus surgical-and non-surgical treatment,
giving an idea of the natural history of the disease in immunosuppressed patients. During a mean follow-up of 8.3 years, 4.5% of our lung transplant recipients developed diverticulitis. This corresponds to an extrapolated incidence of 550 per 100,000 lung transplant recipients, which is about 15 times higher than in the non-immunosuppressed population, where diverticulitis is responsible for approximately 25 to 50 hospital admissions per 100,000 people per year (11), (12) . The diverticulitis rate is identical to a recently published paper on diverticulitis in lung transplant recipients with a short follow-up of 442 days (4.5%)(13) and higher than in pooled data from other transplanted organs, where it was 1.7% (14) . This may be due to the lower level of immunosuppression compared to other types of organ transplantation. Furthermore, consistent with previous data in immunosuppressed patients (2), (15) In the non-immunosuppressed population, selection criteria of patients for elective sigmoid resection after an uncomplicated episode of diverticulitis remain unclear. Recent studies have shown that patients with more than two episodes are not at an increased risk for complications as compared to patients with fewer episodes (19) . In contrast, in transplant patients nonoperative treatment -including antibiotics and short term food restriction -is thought to have a high failure rate, leading to a high mortality (2) . In our presented with a perforated diverticulitis to a later timepoint. Although in other studies the percentage was low, it was not zero (3).
In conclusion, the results of our study have to be interpreted with caution given the small number of patients. However, in line with the current literature and recommendations, our data confirms the higher incidence of diverticulitis-, as well as the higher rate of perforated diverticulitis in lung transplant recipients. Due to high leakage rate after resection with primary anastomosis and protective ileostomy in our cohort of lung transplant recipients with perforated diverticulitis the Hartmann procedure may be the safer option. In contrast to previous findings we observed that uncomplicated diverticulitis in lung transplant recipients can be successfully treated using a non-operative approach even in recurrences thus avoiding morbidity of elective surgery.
Ultimately, these findings might change recommendations towards a higher threshold for elective surgery in immunosuppressed patients. Bigger studies evaluating the risk of perforation at recurrence against the morbidity of elective surgery, as well as more data on the role of primary anastomosis in lung transplant recipients with perforated diverticulitis are needed to ultimately answer these questions.
